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Abstract
Small vessel diseases (SVDs) of the brain are likely to become increasingly common in
tandem with the rise in the aging population. In recent years, neuroimaging and pathologi-
cal studies have informed on the pathogenesis of sporadic SVD and several single gene
(monogenic) disorders predisposing to subcortical strokes and diffuse white matter disease.
However, one of the limitations toward studying SVD lies in the lack of consistent
assessment criteria and lesion burden for both clinical and pathological measures.
Arteriolosclerosis and diffuse white matter changes are the hallmark features of both
sporadic and hereditary SVDs. The pathogenesis of the arteriopathy is the key to under-
standing the differential progression of disease in various SVDs. Remarkably, quantifica-
tion of microvascular abnormalities in sporadic and hereditary SVDs has shown that
qualitatively the processes involved in arteriolar degeneration are largely similar in spo-
radic SVD compared with hereditary disorders such as cerebral autosomal arteriopathy
with subcortical infarcts and leukoencephalopathy (CADASIL). Important significant
regional differences in lesion location within the brain may enable one to distinguish SVDs,
where frontal lobe involvement appears consistently with almost every SVD, but others
bear specific pathologies in other lobes, such as the temporal pole in CADASIL and the
pons in pontine autosomal dominant microangiopathy and leukoencephalopathy or
PADMAL. Additionally, degenerative changes in the vascular smooth muscle cells, the
cerebral endothelium and the basal lamina are often rapid and more aggressive in genetic
disorders. Further quantification of other microvascular elements and even neuronal cells is
needed to fully characterize SVD pathogenesis and to differentiate the usefulness of
vascular interventions and treatments on the resulting pathology.
INTRODUCTION
Small vessel disease (SVD) of the brain is common in community-
dwelling elderly subjects (81, 93, 96). It is now widely accepted
that subcortical ischemic vascular dementia (VaD) results
from SVD (90, 94). The pathogenesis of SVD is still relatively
poorly understood and therapeutic strategies are limited.
Neuroradiologically, SVD is recognized by focal ischemic lesions
or lacunes in the subcortical structures and by diffuse white matter
hyperintensities on T2-weighted magnetic resonance imaging
(MRI) described as leukoaraiosis (90, 97). Patients with SVD
exhibit motor and executive slowing, forgetfulness and dysarthria.
A short-stepped gait is also common and can mimic that of Par-
kinsonism. These may be caused by disruption of pathways
running from the prefrontal cortex to the basal ganglia and of
thalamocortical pathways (94). “Pure” subcortical VaD with a
slowly progressive course may mimic Alzheimer’s disease
(AD) but in the general absence of the characteristic brain
neurofibrillary burden. The main vascular pathological features
involve sclerotic changes in intracranial arteries and arterioles,
whereas parenchymal lesions in the subcortical structures
largely involve lacunar infarcts, microinfarcts, increased
perivascular spacing and deep white matter (WM) attenuation
(Table 1). However, small infarcts or microinfarcts and tissue
thinning may also occur in the cortex. Highly specific cate-
gories of subcortical VaD may be due to infarctions located in
the thalamus with relatively little involvement of other brain
structures (15).
In recent years, much knowledge has come forth from the study
of several monogenic disorders, which model sporadic SVD. Many
of the characteristic clinical and pathological features of these and
other rarer disorders bear considerable similarities to sporadic
SVD (Table 1). In particular, the pathological changes include
progressive arteriopathy, subcortical strokes and WM disease.
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Hereditary SVDs (hSVD) have enormous implications for under-
standing of the pathology and mechanisms in non-cerebral
amyloid angiopathy (CAA)-related sporadic SVD. Hereditary
SVDs are caused by mutations in different genes involving struc-
tural or signaling components of vascular cells (121). Some of
these include cerebral autosomal dominant arteriopathy with
subcortical infarcts and leukoencephalopathy (CADASIL), cer-
ebral autosomal recessive arteriopathy with subcortical infarcts
and leukoencephalopathy (CARASIL), retinal vasculopathy with
cerebral leukodystrophies (RVCL), and collagen type IV, alpha 1
(COL4A1) and alpha 2 (COL4A2)-related disorders. Subcortical
strokes lead to insidious deterioration with most subjects becom-
ing demented in older age. Sporadic SVD characterized by WM
changes on MRI has also been described to be associated with
NOTCH3 gene polymorphisms (98) and exhibits widely variable
phenotypes.
SVD remains a heterogeneous disease, and therefore, one of
the greatest challenges toward studying SVD and relating this to
dementia lies in the lack of consistent assessment tools for both
clinical and pathological measures. For example, most clinical
assessments of cognition in demented cohorts tend to concentrate
on memory focused cognitive assessments used in memory
clinics with a tendency to focus on AD-based dementia. Ideally,
there also needs to be more detailed assessment of vascular
disease-related clinical symptoms such as impaired gait, falls,
depression and incontinence (30). In addition to clinical studies,
there needs to be consistent recognition of the burden of brain
vascular pathology in subjects with SVD in order to relate to
each patient’s clinical symptoms. Achieving this would better
equip us to differentiate the effects of vascular interventions for
prevention of vascular cognitive impairment (VCI) and VaD.
There have been various attempts by neuropathologists to gener-
ate vascular scoring tools, with the aim being one consensus set
of criteria that can be used across multiple studies, and ulti-
mately align and strengthen the datasets available for
clinicopathogical studies (44, 62). As a matter of convenience,
the tools tend to be semiquantitative and highly subjective, yet
there is no standardized or widely accepted quantitative method
for assessing vascular pathology.
This review focuses on highlighting morphological differences
in age-related sporadic and various hSVDs, other than those
caused by CAA, with the intent of identifying and quantifying key
features that inform about the pathogenesis of the arteriopathy and
the parenchymal changes. In addition, we summarize the available
methods to assess microvascular pathology and discuss some
advantages of gathering quantitative data for assessment of the
burden of vascular pathologies that needs attention.
CEREBRAL SVD
Small vessel changes involve hyalinization of vessels, expansion
of the perivascular space and pallor of adjacent perivascular
myelin, with associated astrocytic gliosis (60). The smaller vessels
of the brain including intracerebral end-arteries and arterioles
undergo progressive age-related changes (69). The arteriolar
changes may range from wall thickening by hyalinosis, reduction
or increment of the intima to severe arteriolosclerosis and fibrinoid
necrosis. The careful use of the Periodic acid–Schiff or PAS stain
enables detection of any accumulation of granular material con-
taining glycoproteins or glycolipids within the vessel walls.
Uncomplicated hyalinosis is characterized by almost complete
degeneration of vascular smooth muscle cells (VSMCs) (becomes
acellular) with concentric accumulation of extracellular matrix
components such as the collagens and fibroblasts.
Qualitatively, microvascular changes or their sequences do not
appear to be necessarily different between sporadic SVD and the
hSVDs. In CADASIL and CARASIL, this process is much more
aggressive and intense (19) with many vessels ultimately develop-
ing a double-barrel or wall splitting appearance, particularly in the
most severe cases (Figures 1 and 2). For example, in CADASIL,
medullary arteries of the frontal lobe may exhibit complete loss
of medial smooth muscle cells over their entire length and
severe adventitial fibrosis extending into the WM (86). Although
complete occlusion is not evident, the long penetrating arterioles
and their branches supplying subcortical structures are stenosed
and their walls are thickened by fibrosis, conforming to in-
creased infarcts and primary ischemic damage in the WM (79).
Arteriolosclerotic changes promote loss of elasticity to dilate and
constrict in response to variations of systemic blood pressure or
autoregulation, which, in turn, causes fluctuations in blood flow
response or hemodynamic changes to alter tissue perfusion.
Depending on the size of the microvessels, perfusion changes
result in lacunar infarcts (cystic lesions generally <1 cm) and
microinfarcts. The deep cerebral structures and WM would be
most vulnerable because the vessels are end-arteries almost devoid
of anastomoses. However, certain intrinsic arteriolar systems may
be differentially affected. A recent three-dimensional time-of-
flight MR angiographic on 7T showed that there were no differ-
ences in luminal diameters of the lenticulostriate arteries between
patients with CADASIL and control subjects. The lenticulostriate
artery lumina were also not associated with lacunar infarct load in
the basal ganglia area or with basal ganglia hyperintensities. On
the contrary, a pathological study reported that arteriolar lumina in
the lenticular nuclei were not only larger than in the WM but they
were also larger than in cortical gray matter, which seldom devel-
ops infarcts (78).
In the early stages, small vessel changes likely lead to changes
in the properties of the blood–brain barrier (BBB), with chronic
leakage of fluid and macromolecules resulting in tissue edema (51,
119). Microvascular disease may also be associated with degrees
of inflammation, including the presence of lymphocytes or
macrophages centered on blood vessels (and not necessarily a
function of brain ischemia). In the older SVD cases, there may be
evidence of remote microhemorrhage in the form of perivascular
hemosiderin (24). Unlike microvascular determinants (Figure 3),
quantitative data on neuronal, glial or biochemical changes have
largely not been fully explored across the SVDs.
VASCULAR CELL COMPONENTS
IN SVD
Various cells within the neurovascular unit, including astrocytes,
VSMC, endothelial cells and pericytes, play a role in tissue per-
fusion and hemodynamic responses. Even subtle abnormalities in
these cellular elements would accumulate to affect control of con-
striction and dilation as well as delivery of oxygen, glucose and
nutrients to neuronal tissue.
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Mural cells
VSMCs within arteriolar walls and pre-capillary arterioles
serve as contractile elements and control blood flow responses in
times of increased parenchymal demand (6, 127). Progressive
pathological changes in VSMCs were described in both sporadic
SVD (19) and hereditary SVDs (122). The degenerative process in
CADASIL appears most aggressive almost irrespective of geno-
type. Loss of arterial VSMCs is followed by fibrosis of the tunica
media in small- and medium-sized penetrating arteries (64); arte-
riosclerotic changes are concomitant with stenosis, especially at
the arteriolar level, through intimal thickening and wall expansion
with extracellular matrix components such as collagens, laminin
and fibronectin (75, 79), and compounded by altered protein–
carbohydrate interactions (12, 16, 33). It is not clear whether
failure in NOTCH3 signaling is also responsible for the gradual
degeneration of VSMC in sporadic cases of Binswanger-type or in
hypertensive disease (86, 107). Quantitative VSMC numbers per
vessel segment length in SVDs have not been fully explored, but a
study in CADASIL has suggested that VSMCs undergo apoptosis
akin to neurons in the neocortex (114).
Pericytes
Pericytes juxtaposed to cerebral microvessels, most prominen-
tly wrapped around capillaries have received recent attention
(22, 74). They interact with other cells within the neurovascular
unit by direct contact or cell signaling mechanisms to regulate
Figure 1. Pathological features in small vessel disease (SVD) and cer-
ebral autosomal arteriopathy with subcortical infarcts and leukoen-
cephalopathy (CADASIL). Panels A–C, H and E: D–F are COL4; G–I are
smooth muscle alpha actin; J–L are platelet-derived growth factor
receptor-β. A, D and G are young cognitively normal control, G is old
cognitively normal control; B–K are sporadic SVD; C and L are CADASIL.
Panels A–C illustrate different levels of sclerotic index in control and
disease cases. A is an arteriole from cognitively control case gray matter
in basal ganglia with an external diameter of 145 µm and a SI of 0.28
within the healthy range. B is an arteriole from frontal white matter (WM)
in CADASIL case with an external diameter of 140 µm with an sclerotic
index (SI) of 0.48 within disease state. C is an arteriole from frontal WM
in CADASIL case with an external diameter of 44 µm with severe
sclerosis of vessel wall with a SI of 0.77. D–F. Increased COL4 deposition
observed in sporadic SVD (E) and CADASIL (F). G–I. Loss of vascular
smooth muscle cells in SVD (H) and CADASIL (I) compared with
cognitively normal control (G). J–L. Platelet-derived growth factor
receptor-β staining can be observed in small pre-capillary arterioles,
which undergo hyalinosis in SVD (K) and CADASIL (L). Magnification
bar = 50 µm in J and K; 70 µm in C and L; 150 µm in A, B, D, E, F G and
H. 100 µm in I.
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microcirculatory functions. Pericytes also likely contribute to
pathogenic mechanisms in the smallest arterioles and capillaries.
For example, in CADASIL, we and others (28) have observed
significant abundance of granular osmiophilic material (GOM)
deposits positive for NOTCH3 extracellular domain (N3ECD)
around capillaries within CADASIL brains (122). Platelet-derived
growth factor receptor-β positive pericyte-like cells are increas-
ingly evident in sclerosed arterioles in both CADASIL and
sporadic SVD (Figure 1 and L.J.L. Craggs and R.N. Kalaria,
unpub. data).
Cerebral endothelium
Endothelial cell abnormalities and BBB dysfunction may further
contribute to WM damage. Endothelial changes have been previ-
ously described in SVDs with particular reference to “blebbing,”
change in volume of the cytoplasm and the presence of compact
bundles of microfilaments within the cytoplasm of endothelial
cells in CADASIL (75, 95, 121). Neuroimaging investigations
tracking signal enhancement after gadolinium suggest that break-
down of the BBB (see previous discussion) occurs in areas of
leukoaraiosis and may mediate subsequent cellular changes (117,
118). These changes are associated with chronic prothrombotic
endothelial dysfunction in cerebral SVD (48) also involving
the WM (11). There appears also to be a cerebral response to the
SVD, both sporadic and CADASIL, by increasing endothelial
thrombomodulin (38).
BBB disruption (1) can cause osmotic demyelination and result
in increased permeability of the vessel wall and mobilization of
inflammatory factors, such as macrophages, lymphocytes and
complement, which also causes myelin damage (5). However, the
projected meager perfusion due to capillary loss or abnormalities
occurring prior to leukoaraiosis corroborates the finding of a
chronic hypoxic state in the deep WM (32), which also releases
certain growth-promoting factors (101). It is not clear if
microvascular length density increases in SVD in the most vulner-
able subcortical gray or WM regions as it does in post-stroke
dementia (PSD), which suggests either an increase in angiogenesis
or the formation of newer microvessel loops in response to cerebral
hypoperfusion (14). However, it is likely that microvascular diam-
eters are decreased in SVD as found in VaD, suggesting increased
vasoconstriction.
Figure 2. Differential arteriopathic changes
detected with types of COL in cerebral
autosomal arteriopathy with subcortical
infarcts and leukoencephalopathy (CADASIL).
Panels A, C, E show COL4 immunoreactivity
in arterioles of various sizes. Panels B, D
and F show COL3. The differential
mobilization of COL4 and COL3 can be
readily seen to determine how perivascular
spaces (PVS) are caused. Note the lack of
COL3 reactivity in capillaries (B and D
compared with A and C). Magnification
bar = 130 µm A–D; 70 µm in E and F.
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Vascular basement membrane
The basement membrane of cerebral vessels comprises several
proteins, of which laminins, collagen (COL), nidogens and
perlecans are the major constituents (49). The collagens are the
most often investigated in the context of pathological changes in
basement membranes. They are increased in hypertensive disease
and associated with SVD pathology, which often reveals concen-
trically thickened vessel walls or hyaline arteriolosclerosis (37),
and ultimately decreases the lumen diameter, impinging auto-
vasoreactivity of the vessels described as an “Earthen pipe state”
(86). We evaluated COL4 staining in our cohort of hereditary and
sporadic SVDs and found region-specific differences in COL4
staining in sporadic SVD, PADMAL and Swedish hMID, where
we observed increased COL4 in the frontal lobe of sporadic SVD
cases, whereas the Swedish hMID cases showed increased COL4
within the basal ganglia (122). Comparisons of the different types
of collagens, for example, COL3 and COL4, show the progressive
changes that occur in the mobilization and restructuring of
collagen-containing vascular components (Figure 2). The
pathophysiological significance of basement membrane changes is
also likely to impact on clearance of fluids, solutes and toxins
along the perivascular drainage route (9, 49). Enhanced COL1 and
COL3 deposition has been observed in concentric rings around
veins, too, termed as periventricular venous collagenosis (11, 80).
The type 4 collagens, encoded by multiple genes of which
COL4A1 and COL4A2 are highly conserved, have gained particu-
lar importance in basement membrane changes in SVDs but also
impact on large vessel disease (68). Genetic variation within both
the COL4A1 and the COL4A2 genes have been linked to cerebral
SVDs, which usually occur with systemic vascular abnormalities,
causing a wide range of clinical phenotypes (Table 1). Thus,
COL4A1-related disorders show a range of phenotypes with
overlapping features, including autosomal dominant type 1
porencephaly (40), brain small vessel disease with hemorrhage
(41), brain small vessel disease with Axenfeld-Rieger anomaly
(99), and hereditary angiopathy with nephropathy, aneurysms and
muscle cramps (HANAC) syndrome (92, 109). The consequence
of altered collagen IV proteins within vessel walls is clearly cata-
strophic; infantile intracerebral hemorrhage and hemiparesis are
common with COL4-affected families, and studies in genetically
modified mice expressing mutant COL4A1 have reported 50%
mortality of pups at birth, a problem that was overcome by surgical
delivery (41). In adulthood, subjects with COL4 mutations com-
monly have aneurysms within the carotid and cerebral arteries.
Segments of the most commonly affected arteries include the
intracranial carotid artery, middle cerebral artery and, least fre-
quently, the basilar artery (71), illustrating the vital role collagens
play in vascular wall structure and support.
PARENCHYMAL LESIONS IN SVD
Lacunar infarcts
Lacunar infarcts, occurring as complete or cavitating lesions fre-
quently in both subcortical gray and WM, are the hallmark paren-
chymal lesions for SVD. Neuroimaging studies suggest that
lacunes occur in greater frequency in CADASIL (90) and possibly
other disorders such as CARASIL. They increase with age and are
associated with cognitive impairment (73, 115), but are indistin-
guishable between sporadic or hereditary SVD disorders. Lacunar
infarcts are frequently multiple and bilateral, and often coexist
with other vascular lesions, for example, large infarcts or diffuse
WM damage. Interestingly, the majority of incident lacunes
develop proximal to WM hyperintensities along the course of
perforating vessels supplying the respective brain region. Lesion
prevalence maps in different stages of disease show that lesions
spread toward the subcortical regions in both sporadic SVD and
CADASIL. Whether single or multiple, they may be asympto-
matic, depending on their location and the loss of volume of
normal brain tissue. Lacunar volumes may vary widely and do not
appear to be related to age or associated cerebral lesions such as
WM hyperintensities in CADASIL. However, volumes of lacunar
lesions rather than that of WM hyperintensities affect cortical
depth and other structural changes, supporting the role of the
neocortex in subcortical ischemic VaD (58). Lacunar infarcts and
related microstructural alterations may also affect global brain
volume or atrophy. To distinguish perivascular cavities or spaces, it
has been suggested that lacunes be classed into three subtypes:
lacunar infarcts, lacunar hemorrhages and dilated perivascular
spaces (123). Lacunar infarcts usually result from progressive
SVD manifested as hypertensive angiopathy or possibly
microthrombi that may involve stenosis caused by hyalinosis.
Apart from critical lesions occurring often in the internal capsule
or caudate nucleus, there appear to be no pathological differences
between symptomatic and asymptomatic patients. Perivascular
Figure 3. Pathological substrates of sporadic vs. hereditary small
vessel diseases of the brain. Figure 1 shows the semiquantitative
assessment of vascular pathology in SVDs assessed in frontal lobe
(FWM) or basal ganglia (BG). Mode scores for each group were derived
from a semiquantitative scale of assessment of vascular pathology
giving a summary frontal score out of 6, and basal ganglia score of
out of 4 [ref 24]. Abbreviations: Y Con = young controls; O Con = old
controls; SVD = small vessel disease; CADASIL = cerebral autosomal
dominant arteriopathy with subcortical infarcts and leucoencephalo-
pathy; PADMAL = pontine autosomal dominant microangiopathy and
leucoencephalopathy; Swed hMID = Swedish hereditary multi-infarct
dementia; HERNS = hereditary endotheliopathy with retinopathy, neph-
ropathy and stroke.
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edema and thickening, inflammation and disintegration of the
arteriolar wall were common, whereas vessel occlusion was rare
(4). Occasionally, lacunes may represent small hemorrhages or
dilated perivascular spaces without infarction or hemorrhage.
Microlacunes have also been described in SVD that essentially
should be thought of as large cystic microinfarcts.
WM changes
Diffuse and focal WM lesions are another prominent hallmark of
SVD (54). Neuroimaging and pathological studies show that WM
changes are invariably associated with cognitive abnormalities (23,
82, 90). WM alterations are much more profound in the hereditary
SVDs such as CADASIL and CARASIL. They may occur in the
absence of lacunar infarcts and extensive WM hyperintensities
(WMH) appear associated with increased brain volume, particu-
larly in CADASIL (125). In this disorder, WMH relate not only
to loss of WM components but also to a global increase of
water content in the cerebral tissue. WM hyperintensities on
T2-weighted MRI or leukoaraiosis as a decreased signal on CT
may not only incorporate WM rarefaction, incomplete infarction,
lacunar strokes, perivascular spacing and demyelination, but some-
times also axonal and Wallerian degeneration. Diffusion tensor
imaging (89) has demonstrated how tissue microstructural changes
in WM tracts and subcortical regions, for example, putamen and
thalamus, are related to worsening clinical outcomes in SVD and
CADASIL. The widespread WM axonal changes, particularly in
the frontal lobe, may arise from differential stenosis and sclerosis
of arterioles (20), possibly affecting certain axon bundles connect-
ing to targets in the subcortical structures, specifically degenera-
tion of thalamocortical pathways causing cortical atrophy (59).
There is some controversy as to whether deep or periventricular
lesions are of greater importance but this depends on the definition
of boundaries between the periventricular and deep WM (66).
While lacunar infarcts are produced when the ischaemic damage is
focal and of sufficient severity to result in a small area of necrosis,
diffuse WM change is considered a form of rarefaction or incom-
plete infarction, where there may be selective damage to some
cellular components. Although the U-fibers are frequently spared,
WM disease may comprise several patterns of alterations includ-
ing pallor or swelling of myelin, loss of oligodendrocytes, axons
and myelin fibers, cavitations with or without presence of
macrophages and areas of reactive astrogliosis (100), where the
astrocytic cytoplasm and cell processes may be visible with stand-
ard stains. Lesions in the WM also include spongiosis, that is,
vacuolization of the WM structures and widening of the
perivascular spaces (123).
Whereas WM changes focus on narrowing of the arterial
system, in many cases, occlusion of veins and venules by colla-
genous thickening of the vessel walls also occur. The thickening of
the walls of periventricular veins and venules by collagen
(collagenosis) increases with age, and perivenous collagenosis
(see previous discussion) increases in concert with leukoaraiosis
(8). The presence of apoptotic cells in WM adjacent to areas of
leukoaraiosis suggests that such lesions are dynamic, with progres-
sive cell loss and expansion (7). Vascular stenosis caused by
collagenosis may induce chronic ischemia or edema in the deep
WM leading to capillary loss and more widespread effects on the
brain (9, 10).
Perivascular spaces (PVS)
Dilated PVSs are a frequent finding in the pathology of SVD
(Figure 2). Both neuroimaging and pathological studies show that
the severity of dilated PVS increases with age regardless of the
brain region. Previous neuroimaging studies have indicated that
the size of dilated PVS in the basal ganglia and frontal lobe WM
correlates with cognitive impairment (21, 91). In CADASIL, the
severity of dilated PVS in the temporal lobes or subinsular areas
was found strongly and specifically related to the extent of WMH
(126). Consistent with this finding, we previously demonstrated
that increased volumes of PVS were related toWMmyelin protein
changes (123), suggesting that reduction in WM volume is one
factor that creates PVS. Another important factor involved in the
expansion of PVS is likely the lack of drainage of solutes including
degraded proteins (15).
Incomplete infarcts
Larger areas of incomplete infarction may extend into the WM
(54). These are characterized by mild to moderate loss of
oligodendrocytes, myelin and axons in areas where there may be
hyalinized vessels (13). The parenchymal changes are normally
accompanied by astrogliosis, some microgliosis and macrophage
infiltration with usually no quantification of such response. The
morphology of incomplete or subinfarctive changes, although sus-
pected to be associated with cognitive function, is not consistently
described in SVD. It may variably manifest as tissue rarefaction
assessed by conventional stains and revealed as injury response
such as microgliosis and astrocytosis, or the presence of other
“reactive” cells or surrogate markers of dendritic, synaptic or
axonal damage.
Cerebral microinfarction
The accumulation of small, even miniscule, ischemic lesions is an
important substrate of SVD (60). Microinfarcts may or may not
involve a small vessel at its center but are foci with pallor, neuronal
loss, axonal damage (WM) and gliosis. They are estimated to
occur in their thousands and described as attenuated lesions
of indistinct nature occurring in subcortical regions in sporadic
SVD (24) and hereditary SVDs such as CADASIL (121).
Microinfarction in the subcortical structures has been emphasized
as a substrate of cognitive impairment (3, 60) and correlated with
increased Alzheimer type of pathology, but cortical microinfarcts
also appear to contribute to the progression of cognitive deficits in
brain aging (67). Furthermore, microinfarcts even in border-zone
(watershed) regions may aggravate the degenerative process as
indicated by worsening impairment in AD (106).
Neocortical microinfarcts are increased in the presence of CAA
(84, 103), but are rarely observed in subcortical VaD linked to
SVD (83, 106) or in CADASIL. However, cortical microinfarcts
and, to lesser extent, periventricular demyelination were associated
with cognitive decline in individuals at high risk for dementia (39).
It is proposed that the changes in hemodynamics, for example,
hypotension and atherosclerosis, may play a role in the genesis of
microinfarcts in watershed regions.
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Cerebral microbleeds and hemosiderin
Cerebral microbleeds are an imaging construct to represent ferro-
magnetic hemosiderin iron derived from extravasation of erythro-
cytes. Cerebral microbleeds detected by T2-W* or echo gradient
MRI are also associated with histopathological evidence of
lipohyalinosis and CAA (31). They are likely a surrogate marker of
SVD evident on MRI along with lacunes and WM changes (111).
The prevalence of radiological microbleeds in SVD ranges from
35% to 85%. Both radiological cerebral microbleeds and foci of
hemosiderin containing single crystalloids, or larger perivascular
aggregates, are found in the brains of older subjects including
those diagnosed withVaD and CADASIL (72), but the radiological
and pathological relationship between these findings has not been
entirely clear. Recent evidence suggests that cerebral microbleeds
detected by MRI are a surrogate marker for ischemic SVD rather
than exclusively hemorrhagic diathesis (55). Greater putamen
hemosiderin was significantly associated with indices of small
vessel ischemia, including microinfarcts, arteriolosclerosis,
perivascular spacing and lacunes in any brain region, but not large
vessel disease or whole brain measures of neurodegenerative
pathology. It appears that brain iron homeostasis and small vessel
ischemic change are responsible for these rather than minor epi-
sodes of cerebrovascular extravasation.
ASSESSMENT OF CEREBROVASCULAR
PATHOLOGY
While there are agreed criteria for the assessment of various
dementing disorders, including AD (27, 104), Parkinson disease
dementia (PDD) (26, 29) and dementia with Lewy bodies (76),
there are no widely accepted assessment criteria for VaD (56, 62).
A plethora of literature exists summarizing the nature of cerebro-
vascular disease and associated pathologies, yet there are no
standardized criteria for assessing and reporting cases, and there-
fore studies investigating vascular pathology rely on highly sub-
jective routine or research-based neuropathology reporting. For
example, the National Institute of Aging-Alzheimer’s Association
criteria recommended the assessment of hippocampal sclerosis,
vascular brain injury and microvascular lesions in 12 regions, but
did not specify how lesions should be quantified. Similarly, the
BrainNet European consortium provided survey results from mul-
tiple centers investigating methods used for assessment of vascu-
lar pathology, comparing methods for brain processing and
sampling, through to routine staining protocols, with the conclu-
sion that there is much variation in the procedures (2). Further
variability may come from lack of use of consistent terminology
in reporting vascular pathologies (43). All these factors presum-
ably lead to dichotomies in data with unclear comparisons
between cohorts and datasets. We have attempted to develop cer-
ebrovascular disease scoring tools in an attempt to bridge this
gap, but no method has been widely accepted as the gold standard
(24, 44, 62).
Cerebral vessel sclerosis
The understanding of the cellular mechanisms on how cerebral
arterial vessels alter with age or disease in the absence of athero-
sclerosis is still a matter for investigation. However, the degree of
vessel wall changes is commonly reported in pathological assess-
ments as a way of assessing extent of SVD (Figure 3). This tends
to be qualitative and does not attempt to quantify the true burden.
Nevertheless, some studies have attempted to quantify the patho-
logical changes observed in several cerebrovascular diseases and
provided insights as to how the extent of SVD burden varies in
relation to hypertension, CADASIL and sporadic SVD (Table 2).
The quantitative assessment of vascular wall changes provides a
more sensitive method for comparing between diseases, which
may appear qualitatively the same (19). Additionally, it could also
be presumed that morphometric techniques for the purpose of
measuring vessel wall thickness are less likely to encounter inter-
rater variations. Despite this, there still remains considerable vari-
ation in morphometrical methods used for assessing vessel wall
stenosis, where different investigators use different section thick-
ness, stains and equations to derive the final ratio of vessel wall to
lumen changes (Table 2). The earliest methods on quantifying
cerebral arterial thickening were derived by Furuyama (36) for
assessing the effects of hypertension on systemic arteries.
Furuyama’s method required the radius of an artery’s lumen to the
midpoint of the medial layer “R” and the thickness of the medial
layer “D” were used to calculate the degree of medial layer thick-
ening. This equation was based on the assumption that the ratio
between the radius, that is, distance from lumen center to central
point of the media, and the thickness of medial layer, would
increase as the medial layers become stretched and expanded with
progression of disease, mostly due to uncontrolled hypertension.
Okeda et al (87) utilized this method to assess medial layer thick-
ening in the arachnoid and medullary arteries in several disorders
including Binswanger’s encephalopathy, CADASIL and hyperten-
sion. Despite some limitations of the study, for example, low
sample numbers, their results provided clear evidence of the subtle
differences in the extent of vessel wall changes between disorders,
most notable that CADASIL vessel wall changes were more severe
than those observed in Binswanger’s disease (86). Prior to these
studies, Lammie et al (70) developed the “sclerotic index” (SI)
ratio, where the proportion of external and internal (luminal)
diameter of the vessels is converted to a simple ratio to represent
the extent of lumen narrowing. Using this system, three subclasses
of SI were formulated, where a ratio of 0.2 to 0.3 denoted healthy
vessels, a ratio of 0.3 to 0.5 was considered to be diseased and a
ratio of over 0.5 was denoted as severe. Importantly, this study
examined arterioles across the whole of the cerebrum and provided
qualitative meaning to the SI ratio, using the three tier scale. They
were also able to identify subtle differences to changes in vessels
between the cortical and subcortical regions and compare the deep
gray matter and WM. The SI ratio has since been widely used to
estimate the extent of vessel wall degeneration and stenosis in
morphometric studies. However, there is still no consensus on
the most appropriate section thickness or size of vessels to be
assessed. It is possible that the variations in the above parameters
may explain the varying results. For example, while focusing on
CADASIL, some studies using 5-µm-thick sections have reported
mean SI to be in the region of 0.6–0.7 and for control cases as 0.4,
whereas our studies using sections of 10 µm thickness indicate
estimates comparable to Lammie et al (70): mean SI of 0.4 for
CADASIL and 0.3 for controls.
Another important obvious factor to consider is the size of the
vessels. Okeda et al (86) had first verified that the smaller the
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arteriole, the more severe the vascular smooth muscle loss. Simi-
larly, Miao et al (79) showed that smaller arterioles exhibited
more severe effects of vessel wall thickening on stenosis. In our
study of several SVDs (19), we showed that smaller external
diameters, followed by location were factors in differential
involvement of arterioles between frontal lobe and basal ganglia
locations. We also showed that there was an apparent low burden
of severely sclerosed arterioles with a SI value of >0.5. Previous
studies had reported SI values in CADASIL patients to be well
over 0.5 in most cases; however, while we did observe some
arterioles with SI considered severe, this was only 7.4% of
vessels in the frontal lobe of CADASIL compared with 19.9% of
vessels within the basal ganglia. In comparison, the older spo-
radic SVD subjects had only 6.3% arterioles in the severe cat-
egory in the frontal lobe and 7.3% in the basal ganglia (19). The
large difference between two diseases thought to mirror each
other illustrates the power of morphometric assessment of arte-
riolar sclerosis and provides insights into potential mechanisms
for differences in clinical presentations of subtypes of SVD. Our
study also provided some potential for a threshold of SVD,
which may be related to cognitive function. We found that the
proportion of vessels within the healthy SI range was greater
than 60% in cognitively normal controls, aged between 49 and
94 years of age, whereas in the SVD subjects, there were 36%–
58% in the frontal lobe, and 35%–59% in the basal ganglia, indi-
cating a subtle but potential difference in the cerebral tolerance
to burden of vessel stenosis.
WM changes
Another type of measurable cerebral change attributed to SVD is
attenuation of the WM. We have previously shown that the great-
est loss in myelin staining is encountered in VaD, most of which
exhibited SVD (54). Furthermore, axonal abnormalities are also
evident in SVD. It may be more useful to fully quantify the
extent of WM damage rather than using a semiquantitative 0–3
scoring scale, as in our experience, a WM score of 0–1 is very
rare in any cases aged over 40, and the scale of 2–3 does not
differentiate between age-associated changes in WM damage and
extensive WM damage associated with dementia. We have pre-
viously reported on WM damage in young and old control cases
without significant cognitive impairment and found that their
WM damage may appear extensive enough to score 3 on the
accepted scales (24, 102). While other reliable markers are
urgently needed to assess both myelin and damaged axons, we
showed that amyloid precursor protein immunoreactivity in
axons correlates strongly with severe WM damage albeit in
CADASIL (20). Quantitative measures for WM damage, either
using histochemical stains or quantification of myelin staining
using the myelin index, may allow further differentiation of
subtle changes in WM pathology and delineate mechanisms in
different disorders.
SUMMARY
The recognition of both sporadic and hereditary SVDs and their
variants has enabled greater understanding of the heterogeneity
of cerebrovascular disease. Recent advances in neuroimaging
and quantitative vascular pathology demonstrate how SVD pro-
gresses and results in brain injury related to dementia. Quantifi-
cation of degenerative changes within small cerebral vessels
occurring during older age or caused by genetic defects are pro-
posed to explain the progression of WM changes, resulting in
leukoencephalopathy in both sporadic and monogenic SVDs.
However, the initiating factors causing microvascular changes are
the primary targets driving the progression of sporadic SVD need
to be better understood.
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